[IgE-κ type multiple myeloma achieving complete response with novel agents]

Autor: Tomomi, Takei, Tadao, Ishida, Masahiro, Ikeda, Sumito, Shingaki, Kanji, Miyazaki, Yumiko, Yoshiki, Yu, Abe, Kiyoshi, Okazuka, Seiko, Iki, Nobuhiro, Tsukada, Kenshi, Suzuki
Rok vydání: 2017
Předmět:
Zdroj: [Rinsho ketsueki] The Japanese journal of clinical hematology. 58(11)
ISSN: 0485-1439
Popis: IgE multiple myeloma (MM) is a rare subtype of MM characterized by an aggressive and poor prognosis. Although novel agents have improved the prognosis of MM, there are few case reports of IgE MM treated with these agents. A 53-year-old male patient presented with pain in the right rib and was diagnosed with IgE-κ MM. He was treated with multidrug chemotherapy, including bortezomib and lenalidomide, and underwent autologous stem-cell transplantation (ASCT). Finally, he achieved a complete response after the initiation of pomalidomide. In previous reports, majority of patients with refractory IgE MM treated with novel agents had a poor prognosis. In contrast, patients who were treated with novel agents from the beginning and underwent ASCT had a long-term survival. Overall, the use of novel agents as the first-line therapy is expected to improve IgE MM prognosis.
Databáze: OpenAIRE